Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04995822 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Post Market Clinical Follow-up of EUROSTEM Femoral Stem

StatusActive, Not Recruiting
PhaseNot specified
SponsorEUROS
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv3
  2. Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 10 to 9
    • Primary completion date changed from estimate of Nov 30, 2022 to Nov 6, 2022
    • Study completion date: Nov 30, 2032 to Nov 6, 2032
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
EUROS
4 trials monitored
See all monitored trials
EUROSSTEM is intended for use in primary and revision total hip replacement surgery. Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. As part of post market vigilance, EUROS will collect data on EUROSTEM performances and safety
Trial Details
NCT Number NCT04995822
Lead Sponsor EUROS
Conditions
(from sponsor)		 Hip Osteoarthritis, Hip Arthropathy, Hip Arthritis, Hip Necrosis, Hip Fractures, Hip Dysplasia
Related terms Hip Dislocation, Hip Fractures, Osteoarthritis, Hip
Enrollment 131 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov